EUVIMEDEUVIMED entdecken
Open Access

Pregnancy-associated cancer death in the United States, 2018-2023

Yingxi Chen iD, George Molina, Ting Zhang iD, Lydia M Furman, Christian C Abnet, Rose L Molina

The Oncologist · 09.03.2026 · 31 (4)

DOI: 10.1093/oncolo/oyag076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, online erschienen am 07.03.2026. Verfasst von Yingxi Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, United States. Hauptthemen laut MEDLINE: Pregnancy Complications, Neoplastic, Neoplasms. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Cancer Institute Intramural Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer accounts for about 20% of late maternal deaths in the United States. This study described nationwide patterns of pregnancy-associated cancer mortality among women aged 15-54 years from 2018 to 2023.

Methods

We conducted a serial cross-sectional study using CDC WONDER data, including all live births and pregnancy-associated cancer deaths from 2018 to 2023. Mortality rates were estimated by census region, state, and race and ethnicity, and the proportional contribution of specific cancers was assessed.

Results

During 2018-2023, 731 pregnancy-associated cancer deaths occurred, a rate of 3.3 per 100 000 live births. Non-Hispanic Black women had the highest rate (4.8 per 100 000). Rates varied geographically, with the South highest and the West, particularly California, lowest. Breast cancer, hematologic malignancies, and colorectal cancer together accounted for nearly half of deaths.

Conclusions

Pregnancy-associated cancer mortality varied by region, state, and race and ethnicity, with breast, hematologic, and colorectal cancers as leading causes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy Complications, NeoplasticNeoplasmsHumansFemaleUnited StatesPregnancyAdultCross-Sectional StudiesAdolescentMiddle AgedYoung Adult

Stichwörter der Autor:innen

pregnancy-associated cancer death

Autor:innen und Institutionen

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, United States.
  • Center for Surgery and Public Health, Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115, United States.
  • Ariadne Labs, Brigham and Women's Hospital, Harvard T.H. Chan School of Public Health, Boston, MA 02115, United States.
  • School of Medicine, Case Western Reserve University, Cleveland, OH 44106, United States.
  • Harvard Medical School, Boston, MA 02115, United States.
  • Department Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA 02115, United States.

ORCID-Profile: Yingxi Chen, Ting Zhang

Förderung

  • National Cancer Institute Intramural Research

Zitieren

APA

Chen, Y., Molina, G., Zhang, T., Furman, L. M., Abnet, C. C., & Molina, R. L. (2026). Pregnancy-associated cancer death in the United States, 2018-2023. The Oncologist, 31(4). https://doi.org/10.1093/oncolo/oyag076

Vancouver

Chen Y, Molina G, Zhang T, Furman LM, Abnet CC, Molina RL. Pregnancy-associated cancer death in the United States, 2018-2023. The Oncologist. 2026;31(4). doi:10.1093/oncolo/oyag076

BibTeX
@article{Chen2026,
  author = {Chen, Yingxi and Molina, George and Zhang, Ting and Furman, Lydia M and Abnet, Christian C and Molina, Rose L},
  title = {Pregnancy-associated cancer death in the United States, 2018-2023},
  journal = {The Oncologist},
  year = {2026},
  volume = {31},
  number = {4},
  doi = {10.1093/oncolo/oyag076}
}
Kostenlos starten →